Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up.

Hermann L. Müller,Ursel Gebhardt,Sabine Schröder,Fabian Pohl,Rolf-Dieter Kortmann,Andreas Faldum,Isabella Zwiener,Monika Warmuth-Metz,Torsten Pietsch,Gabriele Calaminus,R Kolb,Christoph Wiegand,N. Sörensen

Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up.

2010

Hermann L. Müller
Ursel Gebhardt
Sabine Schröder
Fabian Pohl
Rolf-Dieter Kortmann
Andreas Faldum
Isabella Zwiener
Monika Warmuth-Metz
Torsten Pietsch
Gabriele Calaminus
R Kolb
Christoph Wiegand
N. Sörensen

Background: Controversies surround various treatment variables for patients with childhood craniopharyngioma such as growth hormone (GH) replacement, which some believe can exacerba

Keywords:

Hormone
Childhood Craniopharyngioma
Internal medicine
Diabetes mellitus
Multivariate analysis
Endocrinology
Hazard ratio
Medicine
prospective trial
growth hormone

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations